A detailed history of Walleye Capital LLC transactions in Geron Corp stock. As of the latest transaction made, Walleye Capital LLC holds 1,656,629 shares of GERN stock, worth $6.61 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,656,629
Holding current value
$6.61 Million
% of portfolio
0.02%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.17 - $4.99 $6.91 Million - $8.27 Million
1,656,629 New
1,656,629 $7.52 Million
Q1 2024

May 15, 2024

SELL
$1.75 - $3.44 $2.1 Million - $4.13 Million
-1,200,543 Reduced 94.12%
74,971 $247,000
Q4 2023

Feb 14, 2024

SELL
$1.74 - $2.31 $1.65 Million - $2.2 Million
-950,552 Reduced 42.7%
1,275,514 $2.69 Million
Q3 2023

Nov 14, 2023

BUY
$2.11 - $3.28 $2.79 Million - $4.34 Million
1,322,938 Added 146.48%
2,226,066 $4.72 Million
Q2 2023

Aug 14, 2023

SELL
$1.97 - $3.69 $5.1 Million - $9.54 Million
-2,586,306 Reduced 74.12%
903,128 $2.9 Million
Q1 2023

May 15, 2023

BUY
$2.14 - $3.4 $4.64 Million - $7.36 Million
2,166,056 Added 163.68%
3,489,434 $7.57 Million
Q4 2022

Feb 14, 2023

BUY
$2.03 - $2.42 $628,181 - $748,866
309,449 Added 30.52%
1,323,378 $3.2 Million
Q3 2022

Nov 14, 2022

BUY
$1.67 - $2.94 $1.69 Million - $2.98 Million
1,013,929 New
1,013,929 $2.37 Million

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.51B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.